Back to RU Rubric Capital Management LP

AMRXAMRX

Showing 8 of 14 quarters

Position history for RURubric Capital Management LP's holdings in Amneal Pharmaceuticals, Inc.

Yes. Rubric Capital Management holds 8,536,755 shares of AMRX (Amneal Pharmaceuticals), worth $171.9M, as of its Q3 2026 13F filing. It reduced the position by 1,631,905 shares (-16.0%) from Q2 2026. Rubric Capital Management has held AMRX since Q2 2023, across 14 quarterly 13F filings. AMRX is 1.6% of Rubric Capital Management's reported 13F portfolio.

Current Value

$171.9M

Current Shares

8.5M

Total Value Change

+$87M

Total Shares Change

-2.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
8.5M
-16.1%
$171.9M1.6%$20.14
0
2026-Q2
Decreased
10.2M
-7.9%
$176M1.6%$17.31
0
2026-Q1
Decreased
11M
-10.5%
$137.2M1.5%$12.43
0
2025-Q4
Unchanged
12.3M
0.0%
$155.4M1.9%$12.60
0
2025-Q3
Increased
12.3M
+5.3%
$123.5M1.4%$10.01
50
2025-Q2
Increased
11.7M
+9.1%
$94.7M1.4%$8.09
51
2025-Q1
Increased
10.7M
+0.1%
$90M1.6%$8.38
47
2024-Q4
Unchanged
10.7M
0.0%
$84.9M1.1%$7.92
0

Optional analytics helps us improve. How it’s used